Enhancing antidepressant safety surveillance: comparative analysis of adverse drug reaction signals in spontaneous reporting and healthcare claims databases

被引:1
|
作者
Kim, Taehyung [1 ,2 ]
Jiang, Xinying [3 ,4 ]
Noh, Youran [1 ,2 ]
Kim, Maryanne [1 ,2 ]
Hong, Song Hee [1 ,2 ]
机构
[1] Seoul Natl Univ, Colleage Pharm, Seoul, South Korea
[2] Seoul Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Seoul, South Korea
[3] Healthcare & Life Sci China, Shanghai, Peoples R China
[4] Renaissance Grp, Shanghai, Peoples R China
基金
新加坡国家研究基金会;
关键词
signal detection; drug safety surveillance; spontaneous reporting system; healthcare claim database; antidepressant; adverse drug reaction; pharmacovigilance; LARGE FREQUENCY TABLES; PERFORMANCE; SYSTEMS;
D O I
10.3389/fphar.2023.1291934
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background/Objective: Spontaneous reporting systems (SRS) such as the Korea Adverse Event Reporting System (KAERS) are limited in their ability to detect adverse drug reaction (ADR) signals due to their limited data on drug use. Conversely, the national health insurance claim (NHIC) data include drug use information for all qualifying residents. This study aimed to compare ADR signal profiles for antidepressants between KAERS and NHIC, evaluating the extent to which detected signals belong to common ADRs and labeling information.Materials and Methods: ADR signal detection in KAERS and NHIC databases, spanning January to December 2017, employed disproportionality analysis. Signal classes were determined based on System Organ Class (SOC) of the Medical Dictionary for Regulatory Activities (MedDRA). Also, Common ADR Coverage (CAC), the proportion of detected signals deemed common ADRs, and labeling information coverage (LIC) represented by mean average precision (mAP) were calculated. Additionally, protopathic bias and relative risk (RR) evaluation were performed to check for signal robustness.Results: Signal detection revealed 51 and 62 signals in KAERS and NHIC databases, respectively. Both systems predominantly captured signals related to nervous system disorders, comprising 33.3% (N = 17) in KAERS and 50.8% (N = 31) in NHIC. Regarding the type of antidepressants, KAERS predominantly reported signals associated with tricyclic antidepressants (TCAs) (N = 21, 41.2%), while NHIC produced most signals linked to selective serotonin reuptake inhibitors (SSRIs) (N = 22, 35.5%). KAERS exhibited higher CAC (68.63% vs. 29.03%) than NHIC. LIC was also higher in KAERS than in NHIC (mAP for EB05: 1.00 vs. 0.983); i.e., NHIC identified 5 signals not documented in drug labeling information, while KAERS found none. Among the unlabeled signals, one (Duloxetine-Myelopathy) was from protopathic bias, and two (duloxetine-myelopathy and tianeptine-osteomalacia) were statistically significant in RR.Conclusion: NHIC exhibited greater capability in detecting ADR signals associated with antidepressant use, encompassing unlabeled ADR signals, compared to KAERS. NHIC also demonstrated greater potential for identifying less common ADRs. Further investigation is needed for signals detected exclusively in NHIC but not covered by labeling information. This study underscores the value of integrating different sources of data, offering substantial regulatory insights and enriching the scope of pharmacovigilance.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Use of adverse events spontaneous reporting for drug safety surveillance in pregnancy
    Hsu, Wan-Ting
    Hernandez-Diaz, Sonia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 360 - 360
  • [2] Impact analysis of signals detected from spontaneous adverse drug reaction reporting data
    Waller, P
    Heeley, E
    Moseley, J
    DRUG SAFETY, 2005, 28 (10) : 843 - 850
  • [3] Impact Analysis of Signals Detected from Spontaneous Adverse Drug Reaction Reporting Data
    Patrick Waller
    Emma Heeley
    Jane Moseley
    Drug Safety, 2005, 28 : 843 - 850
  • [4] Drug Safety Signals Generation Using Disproportionality Analysis of Spontaneous Reporting Databases-A Systematic Review
    Dias, P.
    Penedones, A.
    Mendes, D.
    Fontes-Ribeiro, C.
    Batel-Marques, F.
    DRUG SAFETY, 2014, 37 (10) : 862 - 862
  • [5] Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia
    Adenuga, Babafunso A.
    Kibuule, Dan
    Rennie, Timothy W.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 (03) : 247 - 253
  • [6] A Comparative Analysis of Signal Detection in Electronic Healthcare Databases vs. Spontaneous Reporting Databases
    Pacurariu, Alexandra C.
    Coloma, Preciosa M.
    Trifiro, Gianluca
    Straus, Sabine M.
    Schuemie, Martijn J.
    Gini, Rosa
    Herings, Ron
    Mazzaglia, Giampiero
    Picelli, Gino
    Scotti, Lorenza
    Pedersen, Lars
    van der Lei, Johan
    Sturkenboom, Miriam C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 497 - 497
  • [7] Patient versus Healthcare Professional Spontaneous Adverse Drug Reaction Reporting A Systematic Review
    Inch, Jackie
    Watson, Margaret C.
    Anakwe-Umeh, Stella
    DRUG SAFETY, 2012, 35 (10) : 807 - 818
  • [8] Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam
    Thu Thuy Le
    Thi Thanh Huong Nguyen
    Chi Nguyen
    Ngan Ha Tran
    Lan Anh Tran
    Thanh Binh Nguyen
    Nhung Nguyen
    Hoang Anh Nguyen
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (01) : 122 - 127
  • [9] Pediatric Drug Safety Surveillance: A 10-Year Analysis of Adverse Drug Reaction Reporting Data in Calabria, Southern Italy
    Leporini, Christian
    De Sarro, Caterina
    Palleria, Caterina
    Caccavo, Iolanda
    Piro, Brunella
    Citraro, Rita
    De Sarro, Giovambattista
    DRUG SAFETY, 2022, 45 (11) : 1381 - 1402
  • [10] Pediatric Drug Safety Surveillance: A 10-Year Analysis of Adverse Drug Reaction Reporting Data in Calabria, Southern Italy
    Christian Leporini
    Caterina De Sarro
    Caterina Palleria
    Iolanda Caccavo
    Brunella Piro
    Rita Citraro
    Giovambattista De Sarro
    Drug Safety, 2022, 45 : 1381 - 1402